Cortexyme, Inc.

Patents = 9

Trademarks = 5

Forward Citations = 26

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

7 inventors (with patents filed for the assignee):

Cortexyme, Inc. is a biopharmaceutical company focused on developing therapeutics for Alzheimer's disease and other degenerative disorders. The company's lead candidate, COR388, targets a specific bacterial infection associated with the development of Alzheimer's disease. Cortexyme is pioneering the field of pathogen-targeted therapeutics, with the goal of addressing the root cause of neurodegenerative disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com